(Reuters) -British drugmaker GSK named insider Luke Miels as its CEO designate on Monday to succeed Emma Walmsley, who will step down after nine years in the role. Miels will be tasked with leading a ...
Before the SUV craze kicked off in the USA, only a few rugged models existed - until this Japanese model helped stir up ...